A pioneering systematic review investigated this quiet possibility, executing a rigorous clinical audit of existing data to ask a fundamental question: Can creatine serve as an effective therapeutic ...

A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...

People with depression tend to prefer carbohydrate-rich foods, according to a new study published in Psychological Medicine. The findings point toward the possibility of dietary therapies for ...

On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for ...

A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...

Young women with depression are more likely to have lower levels of taurine in their hippocampus than healthy controls. The corresponding study was published in Biological Psychiatry. Between 2013 and ...

Flow Neuroscience, a small Swedish company treating depression with brain-stimulating headsets, released early data on Monday showing that its device relieved depressive symptoms in clinical trials.

Reunion Neuroscience, a start-up focused on mental health, has raised a $103 million series A round, co-led by MPM BioImpact and the Novo Nordisk Foundation’s investment arm Novo Holdings. The company ...

In 2019, Dr. Amit Etkin left Stanford University to pursue a new way to treat psychiatric disorders like depression and post-traumatic stress disorder. While many treatments for these disorders were ...

Pretty much everyone can agree that the state of America’s collective mental health is lousy. But the jury is very much still out on what exactly is causing the problem. Of course, that’s a ...